home / stock / ctmx / ctmx quote
Last: | $1.32 |
---|---|
Change Percent: | 0.75% |
Open: | $1.32 |
Close: | $1.32 |
High: | $1.39 |
Low: | $1.28 |
Volume: | 1,468,032 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.32 | $1.32 | $1.32 | $1.39 | $1.28 | 1,468,032 | 07-02-2024 |
$1.33 | $1.21 | $1.33 | $1.36 | $1.21 | 1,726,057 | 07-01-2024 |
$1.22 | $1.27 | $1.22 | $1.27 | $1.17 | 2,156,614 | 06-28-2024 |
$1.26 | $1.22 | $1.26 | $1.29 | $1.21 | 1,407,539 | 06-27-2024 |
$1.21 | $1.21 | $1.21 | $1.22 | $1.13 | 3,501,459 | 06-26-2024 |
$1.21 | $1.36 | $1.21 | $1.36 | $1.2 | 2,443,192 | 06-25-2024 |
$1.33 | $1.29 | $1.33 | $1.33 | $1.2799 | 1,257,402 | 06-24-2024 |
$1.29 | $1.26 | $1.29 | $1.35 | $1.26 | 2,245,869 | 06-21-2024 |
$1.28 | $1.29 | $1.28 | $1.31 | $1.26 | 2,120,041 | 06-20-2024 |
$1.29 | $1.42 | $1.29 | $1.42 | $1.28 | 2,201,479 | 06-19-2024 |
$1.29 | $1.42 | $1.29 | $1.42 | $1.28 | 2,201,479 | 06-18-2024 |
$1.37 | $1.37 | $1.37 | $1.4 | $1.33 | 1,671,343 | 06-17-2024 |
$1.38 | $1.45 | $1.38 | $1.485 | $1.375 | 1,635,319 | 06-14-2024 |
$1.46 | $1.5 | $1.46 | $1.53 | $1.43 | 1,501,641 | 06-13-2024 |
$1.49 | $1.51 | $1.49 | $1.54 | $1.45 | 4,740,840 | 06-12-2024 |
$1.49 | $1.61 | $1.49 | $1.63 | $1.475 | 6,095,641 | 06-11-2024 |
$1.63 | $1.65 | $1.63 | $1.69 | $1.61 | 2,255,493 | 06-10-2024 |
$1.64 | $1.66 | $1.64 | $1.69 | $1.62 | 1,176,629 | 06-07-2024 |
$1.67 | $1.69 | $1.67 | $1.69 | $1.58 | 3,511,847 | 06-06-2024 |
$1.67 | $1.69 | $1.67 | $1.73 | $1.64 | 2,103,372 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
CytomX Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a firesid...
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024. “Chris has mad...